Hemoglobin Measured by Orsense NBM-200MP Device and Laboratory Measurement

Comparison of the Hemoglobin Results Obtained With the Orsense NBM-200MP Device and the Clinical Laboratory

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01321593

Enrollment

300

Registered

2011-03-23

Start date

2011-02-28

Completion date

2011-03-31

Last updated

2016-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergency

Brief summary

The purpose of this study is to compare the hemoglobin results obtained with the Orsense NBM-200MP device and the Clinical Laboratory.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* emergency unit patients requiring an hemoglobin determination

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame
Hemoglobin measurement using the Orsense NBM-200MP device	4 months

Countries

France

Outcome results